🟢 Moleculin Biotech is trading 5.59% up today amid likely speculative trading

Moleculin Biotech is trading at $0.56, up 5.59%, with recent volatility and speculative trading appearing more likely than a confirmed catalyst.

• The rebound came on September 24, 2026, after shares closed at $0.53 on September 23.
• No clear company-specific announcement explains the intraday gain. Positive Mexican patent news on September 23 did not prevent the prior session’s decline.
• Broader biotechnology sentiment remains weak, with XBI down 2.04%.